Evidence map›Paper›PMID 34240737›Full record

ArticleThe Biochemical journal2021

C-type cytochrome-initiated reduction of bacterial lytic polysaccharide monooxygenases.

Jessie Branch, Badri S Rajagopal, Alessandro Paradisi, Nick Yates, Peter J Lindley, Jake Smith, Kristian Hollingsworth, W Bruce Turnbull, Bernard Henrissat, Alison Parkin and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Biochemical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Jessie BranchAstbury Centre for Structural Molecular Biology and School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, U.K.
Badri S RajagopalAstbury Centre for Structural Molecular Biology and School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, U.K.
Alessandro ParadisiDepartment of Chemistry, University of York, York YO10 5DD, U.K.
Nick YatesDepartment of Chemistry, University of York, York YO10 5DD, U.K.
Peter J LindleyDepartment of Chemistry, University of York, York YO10 5DD, U.K.
Jake SmithDepartment of Chemistry, University of York, York YO10 5DD, U.K.
Kristian HollingsworthSchool of Chemistry and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, U.K.
W Bruce TurnbullSchool of Chemistry and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, U.K.
Bernard HenrissatArchitecture et Fonction des Macromolécules Biologiques (AFMB), CNRS, Aix-Marseille Université, Marseille, France.
Alison ParkinDepartment of Chemistry, University of York, York YO10 5DD, U.K.
Alan BerryAstbury Centre for Structural Molecular Biology and School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, U.K.
Glyn R HemsworthAstbury Centre for Structural Molecular Biology and School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, U.K.ORCID 0000-0002-8226-1380
University of Leeds · GBUniversity of York · GBCentre National de la Recherche Scientifique · FR

Funding

Biotechnology and Biological Sciences Research Council BB/M012573/1Biotechnology and Biological Sciences Research Council BB/N019970/1
6 · The paper itself

Abstract

The release of glucose from lignocellulosic waste for subsequent fermentation into biofuels holds promise for securing humankind's future energy needs. The discovery of a set of copper-dependent enzymes known as lytic polysaccharide monooxygenases (LPMOs) has galvanised new research in this area. LPMOs act by oxidatively introducing chain breaks into cellulose and other polysaccharides, boosting the ability of cellulases to act on the substrate. Although several proteins have been implicated as electron sources in fungal LPMO biochemistry, no equivalent bacterial LPMO electron donors have been previously identified, although the proteins Cbp2D and E from Cellvibrio japonicus have been implicated as potential candidates. Here we analyse a small c-type cytochrome (CjX183) present in Cellvibrio japonicus Cbp2D, and show that it can initiate bacterial CuII/I LPMO reduction and also activate LPMO-catalyzed cellulose-degradation. In the absence of cellulose, CjX183-driven reduction of the LPMO results in less H2O2 production from O2, and correspondingly less oxidative damage to the enzyme than when ascorbate is used as the reducing agent. Significantly, using CjX183 as the activator maintained similar cellulase boosting levels relative to the use of an equivalent amount of ascorbate. Our results therefore add further evidence to the impact that the choice of electron source can have on LPMO action. Furthermore, the study of Cbp2D and other similar proteins may yet reveal new insight into the redox processes governing polysaccharide degradation in bacteria.

Indexed as

Bacterial ProteinsBiocatalysisCelluloseCellvibrioCytochrome c GroupHydrogen PeroxideIsoenzymesMixed Function OxygenasesModels, MolecularOligosaccharidesOxidation-ReductionOxygenPolysaccharides, BacterialProtein DomainsSpectrophotometrySubstrate SpecificityBacterial ProteinsCelluloseCytochrome c GroupHydrogen PeroxideIsoenzymesMixed Function OxygenasesOligosaccharidesOxygenPolysaccharides, Bacterialbiofuelscytochromeelectron transferLPMOoxidation–reductionprotein structure

Identifiers

PMID34240737
PMCPMC8981238
OpenAlexW3178303947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.